Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
Saved in:
| Title: | Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy. |
|---|---|
| Authors: | Viti R; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy., Marcellusi A; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy. andrea.marcellusi@uniroma2.it.; Institute for Leadership and Management in Health, Kingston University London, London, UK. andrea.marcellusi@uniroma2.it., Capone A; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy., Matucci A; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy., Vultaggio A; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy., Pignata C; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy., Spadaro G; Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, University of Naples Federico II, Naples, Italy., Vacca A; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy., Marasco C; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy., Agostini C; Department of Medicine (DIMED), Internal Medicine 1, Treviso Ca' Foncello Hospital, University of Padua, Padua, Italy., Mennini FS; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.; Institute for Leadership and Management in Health, Kingston University London, London, UK. |
| Source: | Clinical drug investigation [Clin Drug Investig] 2018 Oct; Vol. 38 (10), pp. 955-965. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30191508 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Viti+R%22">Viti R</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Marcellusi+A%22">Marcellusi A</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy. andrea.marcellusi@uniroma2.it.; Institute for Leadership and Management in Health, Kingston University London, London, UK. andrea.marcellusi@uniroma2.it.<br /><searchLink fieldCode="AU" term="%22Capone+A%22">Capone A</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Matucci+A%22">Matucci A</searchLink>; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Vultaggio+A%22">Vultaggio A</searchLink>; Immunoallergology Unit, AOU Careggi, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Pignata+C%22">Pignata C</searchLink>; Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Spadaro+G%22">Spadaro G</searchLink>; Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, University of Naples Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Vacca+A%22">Vacca A</searchLink>; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Marasco+C%22">Marasco C</searchLink>; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Agostini+C%22">Agostini C</searchLink>; Department of Medicine (DIMED), Internal Medicine 1, Treviso Ca' Foncello Hospital, University of Padua, Padua, Italy.<br /><searchLink fieldCode="AU" term="%22Mennini+FS%22">Mennini FS</searchLink>; Economic Evaluation and HTA (EEHTA), CEIS, Faculty of Economics, University of Rome 'Tor Vergata', Rome, Italy.; Institute for Leadership and Management in Health, Kingston University London, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2018 Oct; Vol. 38 (10), pp. 955-965. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30191508 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40261-018-0688-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 955 Titles: – TitleFull: Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Viti R – PersonEntity: Name: NameFull: Marcellusi A – PersonEntity: Name: NameFull: Capone A – PersonEntity: Name: NameFull: Matucci A – PersonEntity: Name: NameFull: Vultaggio A – PersonEntity: Name: NameFull: Pignata C – PersonEntity: Name: NameFull: Spadaro G – PersonEntity: Name: NameFull: Vacca A – PersonEntity: Name: NameFull: Marasco C – PersonEntity: Name: NameFull: Agostini C – PersonEntity: Name: NameFull: Mennini FS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2018 Oct Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1179-1918 Numbering: – Type: volume Value: 38 – Type: issue Value: 10 Titles: – TitleFull: Clinical drug investigation Type: main |
| ResultId | 1 |